In breast cancer, obesity-driven leptin/STAT3 signalling promoted FAO and reduced glycolysis in CD8+ T-effector cells, consequently leading to the inhibition of effector functions and facilitation of tumour growth (94). This evidence concerns the gene STAT3 and breast cancer.